anmelden
SLI
2.141,21
PKT
+1,81
PKT
+0,08
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 28.09.18 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 28.09.18 | Roche Hold | Deutsche Bank AG | |
| 28.09.18 | Novartis Hold | Deutsche Bank AG | |
| 27.09.18 | ABB (Asea Brown Boveri) buy | Citigroup Corp. | |
| 26.09.18 | UBS Underweight | Barclays Capital | |
| 26.09.18 | Zurich Insurance Neutral | UBS AG | |
| 26.09.18 | UBS overweight | JP Morgan Chase & Co. | |
| 25.09.18 | Roche overweight | JP Morgan Chase & Co. | |
| 25.09.18 | Novartis Neutral | UBS AG | |
| 25.09.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.09.18 | Holcim Hold | Kepler Cheuvreux | |
| 25.09.18 | Swiss Re Hold | Commerzbank AG | |
| 25.09.18 | Roche overweight | JP Morgan Chase & Co. | |
| 25.09.18 | Nestlé overweight | JP Morgan Chase & Co. | |
| 25.09.18 | Givaudan overweight | JP Morgan Chase & Co. | |
| 24.09.18 | Nestlé market-perform | Bernstein Research | |
| 24.09.18 | Givaudan verkaufen | Bernstein Research | |
| 20.09.18 | Novartis Equal weight | Barclays Capital | |
| 20.09.18 | Nestlé Neutral | BNP PARIBAS | |
| 20.09.18 | Nestlé overweight | JP Morgan Chase & Co. | |
| 20.09.18 | Nestlé buy | Goldman Sachs Group Inc. | |
| 20.09.18 | Zurich Insurance overweight | JP Morgan Chase & Co. | |
| 19.09.18 | Roche Neutral | UBS AG | |
| 19.09.18 | Nestlé Underperform | Credit Suisse Group | |
| 18.09.18 | UBS buy | Deutsche Bank AG | |
| 18.09.18 | UBS Hold | Deutsche Bank AG | |
| 14.09.18 | Roche Neutral | UBS AG | |
| 14.09.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 14.09.18 | ABB (Asea Brown Boveri) buy | Société Générale Group S.A. (SG) | |
| 12.09.18 | Swiss Re Sell | UBS AG | |
| 12.09.18 | UBS buy | Goldman Sachs Group Inc. | |
| 12.09.18 | UBS Neutral | Goldman Sachs Group Inc. | |
| 11.09.18 | Novartis buy | Citigroup Corp. | |
| 11.09.18 | Novartis Neutral | UBS AG | |
| 11.09.18 | Roche Underperform | BNP PARIBAS | |
| 11.09.18 | Novartis Neutral | BNP PARIBAS | |
| 10.09.18 | UBS buy | Société Générale Group S.A. (SG) | |
| 10.09.18 | UBS buy | Société Générale Group S.A. (SG) | |
| 10.09.18 | Roche Neutral | Merrill Lynch & Co., Inc. | |
| 10.09.18 | Novartis buy | Merrill Lynch & Co., Inc. |